Community Practice

The House of Representatives has followed the Senate in passing long-awaited mental health parity legislation.

This table, prepared by the Centers for Medicare & Medicaid Services, lists the reimbursement rates for prescription drugs and dispensing fees by state.

The U.S. Pharmacopeia has developed a new listing of look-alike, soundalike drug names that are often confused, leading to drug errors.

Roche updates oseltamivir prescribing information.

Pharmacists divided over whether Medicare should require e-prescribing.

PhRMA releases report on neurological drugs in development and Hispanics would benefit most from these products.

CVS opens its 500th MinuteClinic location and plans continued expansion

Two pharmacy schools in California have named new faculty to promote cultural diversity Pharmacy schools train sights on cultural diversity.

Promoting awareness of colon cancer and patient education for March and April.

Professional groups hope community pharmacy can expand provider role.

Palonosetron approved by FDA for postoperative nausea and vomiting.

Palo Alto Labs recalls Aspire36 and Aspire Lite dietary supplements.

The International Academy of Compounding Pharmacists wants to find out when the Food & Drug Administration became interested in cracking down on the use of estriol for bio-identical hormone replacement therapy.

A nonprofit group concerned over short stature in kids opposes legislation now under consideration in Congress that would move human growth hormone into Schedule III of the Controlled Substances Act.

AMA asks patients if they know what expired medicines are in their homes.

Desvenlafaxine is approved by FDA for depression in adults.

Expanded labeling approved for sitagliptin/metformin.

Baxter Healthcare Corp. recalls remaining heparin lots.

FDA advisory on ingestion of tiotropium and formoterol capsules

Aripiprazole approved for new indication.

NACDS Foundation promotes use of a personal medication record to help patients

New recommendations regarding diet represent a departure from the past.

Liver injury warnings added to natalizumab prescribing information.

Esomeprazole approved for children.